Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial.
Romesser PB, Sherman EJ, Whiting K, Ho ML, Shaha AR, Sabra MM, Riaz N, Waldenberg TE, Sabol CR, Ganly I, McBride SM, Fagin JA, Zhang Z, Tuttle RM, Wong RJ, Lee NY.
Romesser PB, et al. Among authors: ho ml.
Cancer. 2021 Nov 15;127(22):4161-4170. doi: 10.1002/cncr.33804. Epub 2021 Jul 22.
Cancer. 2021.
PMID: 34293201
Free PMC article.
Clinical Trial.